Literature DB >> 28420606

Epigenetic regulation and related diseases during placental development.

Fu-lin Liu1, Jin Zhou2, Wei Zhang3, Hui Wang4.   

Abstract

The placenta is vital to fetal growth and development, as it bridges the fetus and the mother. Genome-wide epigenetic regulations (e.g., DNA methylation, histone modifications, non-coding RNAs) participate in many aspects of placenta development, including decidua of the uterus, trophoblast cell adhesion and invasion, angiogenesis and placental imprinted gene expression. Environmental factors during pregnancy, such as heavy metals, chemical compounds, modern assisted reproductive technology and the nutrient conditions, may cause abnormal placental epigenetics. Furthermore, sex differential expression of placental genes also contributes to epigenetic modifications. As prenatal DNA methylation analysis can detect abnormal epigenetic modifications, it is a potential diagnosis tool for early stage diseases and may help disease intervention and treatment. Here, we review not only regulations of epigenetic modifications during development of the placenta, but also the influences of environmental factors. The potential value for diagnosis and treatment is also discussed.

Mesh:

Year:  2017        PMID: 28420606     DOI: 10.16288/j.yczz.16-380

Source DB:  PubMed          Journal:  Yi Chuan        ISSN: 0253-9772


  2 in total

1.  Endocrine Disrupting Chemicals, Transgenerational Epigenetics and Metabolic Diseases.

Authors:  Aliya Feroe; Richard Broene; David Albuquerque; Patricia Ruiz
Journal:  EC Endocrinol Metab Res       Date:  2017-11

Review 2.  DNA methylation in human lipid metabolism and related diseases.

Authors:  Kirstin Mittelstraß; Melanie Waldenberger
Journal:  Curr Opin Lipidol       Date:  2018-04       Impact factor: 4.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.